FDA Center For Biologics Evaluation And Research
Part of Department Of Health And Human Services
The FDA Center for Biologics Evaluation and Research (CBER) is dedicated to ensuring the safety, purity, and potency of biological therapeutics, including vaccines, gene therapies, blood products, and advanced cell-based treatments. Its mission centers on advancing regulatory science through cutting-edge laboratory capabilities, diagnostic innovation, and rigorous quality assurance systems.
FDA Center For Biologics Evaluation And Research is a government agency with procurement activity across contracts, awards, and contractors.
